Home
>
National Drug Code (NDC)
>
VIRACEPT
VIRACEPT - 55289-477-27 - (nelfinavir mesylate)
Drug Information of VIRACEPT
| Product NDC: | 55289-477 |
| Proprietary Name: | VIRACEPT |
| Non Proprietary Name: | nelfinavir mesylate |
| Active Ingredient(s): | 250 mg/1 & nbsp; nelfinavir mesylate |
| Administration Route(s): | ORAL |
| Dosage Form(s): | TABLET, FILM COATED |
| Coding System: | National Drug Codes(NDC) |
Labeler Information of VIRACEPT
| Product NDC: | 55289-477 |
| Labeler Name: | PD-Rx Pharmaceuticals, Inc. |
| Product Type: | HUMAN PRESCRIPTION DRUG |
| FDA Application Number: | NDA020779 |
| Marketing Category: | NDA |
| Start Marketing Date: | 19970314 |
Package Information of VIRACEPT
| Package NDC: | 55289-477-27 |
| Package Description: | 27 TABLET, FILM COATED in 1 BOTTLE, PLASTIC (55289-477-27) |
NDC Information of VIRACEPT
| NDC Code | 55289-477-27 |
| Proprietary Name | VIRACEPT |
| Package Description | 27 TABLET, FILM COATED in 1 BOTTLE, PLASTIC (55289-477-27) |
| Product NDC | 55289-477 |
| Product Type Name | HUMAN PRESCRIPTION DRUG |
| Non Proprietary Name | nelfinavir mesylate |
| Dosage Form Name | TABLET, FILM COATED |
| Route Name | ORAL |
| Start Marketing Date | 19970314 |
| Marketing Category Name | NDA |
| Labeler Name | PD-Rx Pharmaceuticals, Inc. |
| Substance Name | NELFINAVIR MESYLATE |
| Strength Number | 250 |
| Strength Unit | mg/1 |
| Pharmaceutical Classes | HIV Protease Inhibitors [MoA],Protease Inhibitor [EPC] |
